APA (7th ed.) Citation

Group, A. a. L. T. t. P. H. A. T. C. R., & Trial, A. O. a. C. f. t. A. C. R. G. T. A. a. L. T. t. P. H. A. (2002). Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA: Journal of the American Medical Association, 288(23), 2981.

Chicago Style (17th ed.) Citation

Group, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research, and ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. "Major Outcomes in High-risk Hypertensive Patients Randomized to Angiotensin-converting Enzyme Inhibitor or Calcium Channel Blocker Vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)." JAMA: Journal of the American Medical Association 288, no. 23 (2002): 2981.

MLA (9th ed.) Citation

Group, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research, and ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. "Major Outcomes in High-risk Hypertensive Patients Randomized to Angiotensin-converting Enzyme Inhibitor or Calcium Channel Blocker Vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)." JAMA: Journal of the American Medical Association, vol. 288, no. 23, 2002, p. 2981.